Similar Articles
151 Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy
152 Multidisciplinary approaches in the management of advanced hepatocellular carcinoma: Exploring future directions
153 Intratumoural microorganism can affect the progression of hepatocellular carcinoma
154 Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma
155 Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy
156 Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages
157 Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report
158 Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model
159 Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus
160 Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA